Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSELTAMIVIR vs OSIMERTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OSELTAMIVIR vs OSIMERTINIB: Safety Overview

Metric OSELTAMIVIR OSIMERTINIB
Total FAERS Reports 11,686 27,750
Deaths Reported 1,045 12,456
Death Rate 8.9% 44.9%
Hospitalizations 2,284 5,277
Average Patient Age 42.4 yrs 68.2 yrs
% Female Patients 54.2% 66.0%
FDA Approval Date Aug 3, 2016 Nov 13, 2015
Manufacturer Proficient Rx LP AstraZeneca Pharmaceuticals LP
Route ORAL ORAL
Marketing Status Prescription Prescription